Reflections from the TB Vax ARM Webinar on the #Wins4TBVax

Thursday, 4 April 2024 The TB Vaccine Advocacy Roadmap (TB Vax ARM) were joined by Birgitte Giersing (WHO), Rupali Limaye (SMART4TB), Suvanand Sahu (Stop TB Partnership), and Maiko Tonini (Ministry of Health, Brazil) at the #Wins4TBVax webinar on Thursday 4 April. The #Wins4TBVax outline key advocacy goals for the field to achieve by 2026 to…

Read More

Summary: 2023 Working Group on New TB Vaccines Annual Meeting

The Stop TB Partnership Working Group on New TB Vaccines (WGNV) held its first annual meeting on 14 November 2023. The meeting was part of a full-day New TB Tools Summit – a collaboration between WGNV, the Stop TB Partnership’s Working Group on New Drugs and New Diagnostics Working Group, TB Alliance, FIND, and IAVI…

Read More

All eyes on new TB vaccines – but what’s next after the HLM on TB?

Last month’s 78th United Nations (UN) General Assembly was a major week for global health, with back-to-back High-Level Meetings (HLMs) on Pandemic, Preparedness, and Response (PPR), Universal Health Coverage (UHC), and the second HLM on Tuberculosis (TB). This time round, TB vaccines were firmly in the spotlight – a sea change in support compared to…

Read More

Career Paths in TB Research: Technical and Academic Paths

The Working Group on New TB Vaccines (WGNV) Early Career Researcher Network (ECR Network) recently held the first two virtual discussion sessions in a series on career paths in TB research. Technical/Non-Academic Path On the 15th of February, Dr. Mike Leipold, a Research and Development Scientist at Stanford University, tackled the often-pondered question of “if…

Read More

TB Vaccine Modeling: A discussion with Dr. Richard White

Vaccine production, from the product concept to development to licensure to deployment is inherently costly and risky for manufacturers, particularly for vaccines against diseases where the burden lies predominantly in lower- and middle-income countries (LMICs). Thus, vaccine manufacturers frequently prioritize high-income markets that offer higher immediate return on investment. The World Health Organization has been…

Read More